AUTH/2123/5/08: General practitioner v Sandoz Ltd – promotional email sent via agency (no breach)

📅 2008 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2123/5/08
Case referenceGeneral practitioner v Sandoz
ComplainantA general practitioner
Respondent/companySandoz Ltd
Product(s)Fentanyl Mezolar Matrix; Fentalis Reservoir
Material/channelPromotional email sent by an agency on behalf of Sandoz, linking to a webpage with product information and SPCs
Key issueWhether promotional emails were sent without prior permission; responsibility for third-party email activity
Dates (received/completed if stated)Complaint received 24 April 2008; Case completed 30 July 2008
AppealNot stated
Code yearNot stated
Breaches/clausesClause 9.9 (no breach)
SanctionsNo explicit additional sanctions stated beyond the required undertaking/corrective actions described in the report

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
📋

What happened

  • A general practitioner complained about large “junk” emails sent by/for Sandoz Ltd which filled clinical inboxes and slowed computers.
  • The complainant said they had tried to stop receipt (including junk mail rules), but the agency used multiple email addresses which circumvented filters.
  • The Authority asked Sandoz to respond in relation to Clause 9.9 (use of email for promotional purposes).
  • Sandoz said the emails were part of a marketing activity delivered by an agency to NHS recipients who had consented to receive information via/from the agency.
  • Sandoz said the email linked to a webpage containing an independent article (pain therapy), additional information about Sandoz products (Fentanyl Mezolar Matrix and Fentalis Reservoir), and the SPCs for those products.
  • Sandoz stated it relied on the agency to have obtained consent and, following the complaint, told the agency it had serious concerns about its database and records.
  • The agency’s process described included telephone contact to obtain an email address for an access code to its NHS online directory service, followed by a confirmation email; emails also included an opt-out facility.
  • The Panel noted the complainant did not respond to a request to allow the Authority to reveal their identity to Sandoz, limiting what could be checked about consent timing/records.
⚖️

Outcome

  • The Panel considered the email was clearly promotional material.
  • The Panel reiterated that companies are responsible under the Code for work undertaken by third parties on their behalf.
  • The Panel could not determine when the complainant’s details were added to the agency database (and therefore whether the relevant permission wording applied).
  • In the circumstances, the Panel considered there was nothing further that could be done and ruled no breach of Clause 9.9.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Charter Member — Until 31 March

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export. £1,999/year £2,499

Get Charter Access →

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free